PerkinElmer Inc (PKI)

Add to Watchlists
Create an Alert
Quickflows
98.80 -0.98  -0.98% NYSE Jan 27, 10:02 Delayed 2m USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All PKI News

News

View All Events

Events

Date Type Description
04/24/2020 17:00 EDT Misc PerkinElmer Inc First Quarter Earnings Conference Call in 2020
04/24/2020 Earnings PerkinElmer Inc First Quarter Earnings in 2020 Release
04/16/2020 Dividends Amount: 0.07, Declared Date: Jan 23 2020, Pay Date: May 08 2020
01/27/2020 17:00 EST Misc PerkinElmer Inc Fourth Quarter Earnings Conference Call for 2019
01/27/2020 Earnings PerkinElmer Inc Fourth Quarter Earnings in 2019 Release
01/16/2020 Dividends Amount: 0.07, Declared Date: Oct 24 2019, Pay Date: Feb 07 2020
10/30/2019 17:00 EDT Misc PerkinElmer Inc Third Quarter Earnings Conference Call for 2019
10/30/2019 Earnings PerkinElmer Inc Third Quarter Earnings in 2019 Release
10/17/2019 Dividends Amount: 0.07, Declared Date: Jul 25 2019, Pay Date: Nov 08 2019
07/29/2019 17:00 EDT Misc PerkinElmer Inc Second Quarter Earnings Conference Call in 2019
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 2.835B
Total Expenses (TTM) 2.469B
Net Income (TTM) 234.35M

Balance Sheet View Statement

Total Assets (Quarterly) 6.489B
Total Liabilities (Quarterly) 3.782B
Shareholders Equity (Quarterly) 2.707B

Cash Flow Statement View Statement

Cash from Operations (TTM) 307.68M
Cash from Investing (TTM) -403.50M
Cash from Financing (TTM) 344.06M

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.perkinelmer.com
  • Investor Relations URL: http://www.perkinelmer.com/corporate/investors
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Jan. 27, 2020
  • Last Earnings Release: Jan. 27, 2020
  • Next Ex-Dividend Date: Apr. 16, 2020
  • Last Ex-Dividend Date: Jan. 16, 2020
  • Description: PerkinElmer provides instruments, consumables, and services to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes prenatal screening and infectious disease testing, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening to environmental analytical tools.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 98.80
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
UTRN Vesper US Large Cap S-T Rvrsl Stgy ETF 3.94%
ITCTX VY® T. Rowe Price Capital Apprec S2 3.17%
PACLX T. Rowe Price Capital Appreciation Adv 2.94%
ACT AdvisorShares Vice ETF 2.57%
EBCGX MFS Mid Cap Growth 529B 2.39%
NUMG Nuveen ESG Mid-Cap Growth ETF 1.81%
RYH Invesco S&P 500® Equal Wt Hlth Care ETF 1.68%
JDMRX Janus Henderson Enterprise R 1.55%
VISVX Vanguard Small Cap Value Index Inv 0.51%
VBR Vanguard Small-Cap Value ETF 0.51%
NAESX Vanguard Small Cap Index Inv 0.27%
VB Vanguard Small-Cap ETF 0.27%

Comparables

Edit
BRKR Bruker Corp
A Agilent Technologies Inc
BIO Bio-Rad Laboratories Inc
HBIO Harvard Bioscience Inc
HOLX Hologic Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.